Stefan Hartl

Dr. Stefan Hartl

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2023 in Korean Circulation Journal
Verified
Journal Article
Open access
PDF file
SHStefan Hartl
Stefan Hartl
NRNico Reinsch
Nico Reinsch
AFAnna Füting
Anna Füting
KNKars Neven
Kars Neven
Korean Circulation Journal 대한심장학회지 순환기 Hartl S, et al. Korean Circ J. 2023 Mar;53:e26. https://doi.org/10.4070/kcj.2023.0023

2 July 2024 in EP Europace
Verified
Journal Article
Open access
PDF file
NRNico Reinsch
Nico Reinsch
AFAnna Füting
Anna Füting
SHStefan Hartl
Stefan Hartl
DHDennis Höwel
Dennis Höwel
EREva Rausch
Eva Rausch
KNKars Neven
Kars Neven
Pulsed field ablation (PFA) is a novel, non-thermal, cardiac tissue-selective ablation modality. To date, radiofrequency (RF)-guided high-power short-duration (HPSD) ablation represents the gold standard besides cryo-ablation for pulmonary vein isolation (PVI). This single-centre, retrospective study investigated the efficacy of PFA-PVI vs. HPSD-RF PVI in terms of single-procedure arrhythmia-free outcome and safety in a real-world setting. Consecutive, paroxysmal atrial fibrillation (AF) patients who underwent PVI using PFA or HPSD-RF were enrolled. In group PFA, PVI was performed using a pentaspline PFA catheter. The ablation procedure in group HPSD-RF was performed with RF energy (45 W, ablation index). A total of 410 patients (group PFA, 201; group HPSD-RF, 209) were included. There was no difference between both groups regarding age, gender, and CHA2DS2-VASc score. The procedure time was significantly shorter in group PFA [61 (44–103) vs. 125 (105–143) min; P < 0.001]; fluoroscopy time and dose area product were significantly higher in group PFA [16 (13–20) vs. 4 (2–5) min; P < 0.01 and 412 (270–739) vs. 129 (58–265) μGym2; P < 0.01]. The overall complication rates were 2.9% in group PFA and 6.2% in group HPSD (P = 0.158). There was one fatal stroke in the PFA group. The 1-year Kaplan–Meier estimated freedom from any atrial tachyarrhythmia was 85% with PFA and 79% with HPSD-RF (log-rank P = 0.160). In 56 repeat ablation procedures, the PV reconnection rate was 30% after PFA and 38% after HPSD-RF (P = 0.372). Both PFA and HPSD-RF were highly efficient and effective in achieving PVI in paroxysmal AF patients. The arrhythmia-free survival is comparable. The PV reconnection rate was not different.

1 April 2023 in Circulation: Arrhythmia and Electrophysiology
Verified
Journal Article
Closed access
AFAnna Füting
Anna Füting
NRNico Reinsch
Nico Reinsch
LBLenny Brokkaar
Lenny Brokkaar
SHStefan Hartl
Stefan Hartl
DHDennis Höwel
Dennis Höwel
KNKars Neven
Kars Neven
Background: Thermal left atrial ablation can cause bronchial damage. Pulsed field ablation (PFA) is a novel, nonthermal ablation modality for paroxysmal atrial fibrillation. We report on bronchial effects after pulmonary vein isolation using PFA for paroxysmal atrial fibrillation. Methods: A computed tomography scan showing the respiratory tract adjacent to the left atrial was obtained. Oral anticoagulation was interrupted on procedure day. Peri-procedurally, patients received heparin with an activated clotting time goal of >350 seconds. All pulmonary veins were individually isolated with a 13F steerable sheath and a pentaspline PFA catheter using either a straight-tip or J-tip guide wire. The J-tip guide wire patients were added to test the hypothesis that the straight-tip guidewire was associated with bleeding complications. One day afterward, bronchoscopy was performed. Serial hemoglobin levels were measured during 30-day follow-up. Results: In 2 series of 30 patients, PFA was performed, with all pulmonary veins acutely isolated. Clinical course was uneventful, no patient had chest discomfort, coughing, or hemoptysis. All patients underwent uncomplicated bronchoscopy, without thermal lesions or ulcers. In 12 out of 30 (40%) straight-tip guide wire patients, small amounts of old blood without active bleeding were seen in multiple segments. All hemoglobin levels remained clinically stable. At 30-day follow-up, all patients were asymptomatic. Conclusions: Pulmonary vein isolation using PFA for paroxysmal atrial fibrillation does not cause thermal lesions in the bronchial system. Use of a straight-tip, extrastiff guide wire for the over-the-wire PFA catheter can lead to asymptomatic bleeding in the bronchial system without clinical relevance at 30-day follow-up, opposite to use of a J-tip guide wire.

28 February 2021 in Journal of Cardiovascular Electrophysiology
Verified
Journal Article
Open access
PDF file
SHStefan Hartl
Stefan Hartl
UDUwe Dorwarth
Uwe Dorwarth
JPJanis Pongratz
Janis Pongratz
FAFlorian Aurich
Florian Aurich
BBBenedikt Brück
Benedikt Brück
FSFlorian Straube
Florian Straube
Introduction: The objective was to analyze the impact of patient age on clinical characteristics, procedural results, safety, and outcome of cryoballoon ablation (CBA) as the primary approach in the interventional treatment of symptomatic atrial fibrillation (AF).Methods and Results: The single‐center prospective observational study investigated consecutive patients who underwent initial left atrial ablation for symptomatic paroxysmal (PAF) or persistent AF (persAF). Age groups (A–F) of less than 40, 40–49, 50–59, 60–69, 70–79 and more than or equal to 80 years were evaluated. Follow‐up (FU) included ECG, Holter monitoring and assessment of AF‐symptoms. From 2012 to 2016, a total of 786 patients (64 ± 11 years, range 21–85) underwent CBA. With advancing age, more cardiovascular comorbidities and larger LA diameter were observed, more females were included (each p < .001). PAF (57%) and persAF (43%, p = .320) were equally distributed over all age groups. Age was neither related to procedural parameters, nor to the complication rate (3.9%, p = .233). Median FU was 38 months. Two non‐procedure related noncardiac deaths occurred late during FU. Freedom from arrhythmia was independent of age at 18 months (p = .210) but decreased for patients more than or equal to 70 years at 24 months (p = .02). At 36 months, freedom from arrhythmia was 66%–74% (groups A–D), 54% (E) and 49% (F), respectively (p = .002). LA diameter and persAF were independent predictors, whereas age was a dependent predictor of recurrence.Conclusion: CBA as the primary approach in the initial ablation procedure is safe and highly effective in the young, middle aged, and elderly population. LA diameter and persAF, but not ageing, were independent predictors for arrhythmia recurrence.

6 October 2025 in Arrhythmia and Electrophysiology Review
Verified
Journal Article
Open access
PDF file
KNKars Neven
Kars Neven
AFAnna Füting
Anna Füting
SHStefan Hartl
Stefan Hartl
NRNico Reinsch
Nico Reinsch
Pulsed field ablation (PFA) represents a paradigm shift in the catheter-based treatment of AF, offering myocardial-selective ablation through the non-thermal mechanism of irreversible electroporation. Despite promising early outcomes, the durability of PFA lesions, particularly over mid- and long-term follow-up, remains a critical area of investigation. This review incorporates preclinical and clinical data on PFA lesion durability, explores biophysical underpinnings, evaluates procedural variables influencing outcomes, and identifies ongoing challenges and future research priorities.

28 October 2021 in Journal of Thoracic Imaging
Verified
Journal Article
Closed access
Christian TescheChristian Tesche
Christian Tesche
MBMoritz Baquet
Moritz Baquet
MBMaximilian J. Bauer
Maximilian J. Bauer
FSFlorian Straube
Florian Straube
SHStefan Hartl
Stefan Hartl
UEUllrich Ebersberger
Ullrich Ebersberger
Purpose: To investigate the long-term prognostic value of coronary computed tomography angiography (cCTA)-derived plaque information on major adverse cardiac events (MACE) in patients with and without diabetes mellitus. Materials and Methods: In all, 64 patients with diabetes (63.3±10.1 y, 66% male) and suspected coronary artery disease who underwent cCTA were matched with 297 patients without diabetes according to age, sex, cardiovascular risk factors, and statin and antithrombotic therapy. MACE were recorded. cCTA-derived risk scores and plaque measures were assessed. The discriminatory power to identify MACE was evaluated using multivariable regression analysis and concordance indices. Results: After a median follow-up of 5.4 years, MACE occurred in 31 patients (8.6%). In patients with diabetes, cCTA risk scores and plaque measures were significantly higher compared with nondiabetic patients (all P<0.05). The following plaque measures were predictors of MACE using multivariable Cox regression analysis (hazard ratio [HR]) in patients with diabetes: segment stenosis score (HR=1.20, P<0.001), low-attenuation plaque (HR=3.47, P=0.05), and in nondiabetic patients: segment stenosis score (HR=1.92, P<0.001), Agatston score (HR=1.0009, P=0.04), and low-attenuation plaque (HR=4.15, P=0.04). A multivariable model showed a significantly improved C-index of 0.96 (95% confidence interval: 0.94-0.0.97) for MACE prediction, when compared with single measures alone. Conclusion: Diabetes is associated with a significantly higher extent of coronary artery disease and plaque features, which have independent predictive values for MACE. cCTA-derived plaque information portends improved risk stratification of patients with diabetes beyond the assessment of obstructive stenosis on cCTA alone with subsequent impact on individualized treatment decision-making.